Luminex Receives CE Marking for Aries System, Herpes Assay | GenomeWeb

NEW YORK (GenomeWeb) – Luminex today announced that it has received CE-IVD Marking for its Aries system and Aries Herpes Simplex Virus (HSV) 1&2 Assay.

"We are excited to have received a CE-IVD mark for the ARIES System and … HSV 1&2 Assay, and look forward to rapidly launching this revolutionary system in Europe," Thomas Pracht, Luminex managing director for Europe, Middle East, India, and Africa, said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.

Mar
23
Sponsored by
Personal Genome Diagnostics

This webinar will discuss genomic methods to elucidate the molecular mechanisms underlying acquired resistance to immuno-oncology (IO) therapies.

Mar
28

This webinar describes the optimization and validation of two commercially available next-generation sequencing assays that may be used to guide personalized cancer treatment. 

Apr
18
Sponsored by
Twist BioScience

This webinar will cover methodologies for genome-wide screening with CRISPR/Cas9 in human pluripotent stem cells (hPSCs).